Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition
This study identifies a promising genomically-tailored therapeutic strategy for bithalamic gliomas, a lethal and genetically distinct brain tumor of childhood.
Source: Acta Neuropathologica - Category: Neurology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Children | Genetics | Glioma | Neurology | Pediatrics | Study